4//SEC Filing
Jansen Burkhard 4
Accession 0001209191-21-005920
CIK 0001651944other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 6:19 PM ET
Size
7.4 KB
Accession
0001209191-21-005920
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Jansen Burkhard
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-26$6.94/sh+5,000$34,700→ 79,037 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-26−5,000→ 16,244 totalExercise: $6.94Exp: 2026-03-14→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]This reported disposition reflects the exercise of an option. The shares of common stock issued upon exercise of this option remain subject to the restrictions contemplated by the lock-up agreement, dated January 1, 2021, by and among the reporting person, the issuer, and the representatives of the several underwriters of the issuer's January 2021 public offering of common stock.
- [F2]This option is fully vested and exercisable.
Documents
Issuer
DermTech, Inc.
CIK 0001651944
Entity typeother
Related Parties
1- filerCIK 0001787132
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 6:19 PM ET
- Size
- 7.4 KB